nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—Erlotinib—kidney cancer	0.0934	1	CbGbCtD
Cefotetan—Blood bilirubin increased—Paclitaxel—kidney cancer	0.00537	0.00592	CcSEcCtD
Cefotetan—Vaginal moniliasis—Doxorubicin—kidney cancer	0.00532	0.00587	CcSEcCtD
Cefotetan—Neutropenia—Everolimus—kidney cancer	0.00531	0.00585	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Sorafenib—kidney cancer	0.00513	0.00566	CcSEcCtD
Cefotetan—Neutropenia—Erlotinib—kidney cancer	0.00512	0.00565	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Doxorubicin—kidney cancer	0.00511	0.00563	CcSEcCtD
Cefotetan—Hepatic function abnormal—Gemcitabine—kidney cancer	0.00504	0.00556	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Sunitinib—kidney cancer	0.00494	0.00545	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Doxorubicin—kidney cancer	0.00491	0.00542	CcSEcCtD
Cefotetan—Colitis—Paclitaxel—kidney cancer	0.00487	0.00538	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00484	0.00534	CcSEcCtD
Cefotetan—Leukopenia—Temsirolimus—kidney cancer	0.00476	0.00525	CcSEcCtD
Cefotetan—Agranulocytosis—Vinblastine—kidney cancer	0.00474	0.00523	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Dactinomycin—kidney cancer	0.00468	0.00516	CcSEcCtD
Cefotetan—Neutropenia—Sorafenib—kidney cancer	0.00461	0.00508	CcSEcCtD
Cefotetan—Convulsion—Temsirolimus—kidney cancer	0.00461	0.00508	CcSEcCtD
Cefotetan—Haemoglobin—Vinblastine—kidney cancer	0.00458	0.00506	CcSEcCtD
Cefotetan—Haemoglobin—Everolimus—kidney cancer	0.00457	0.00504	CcSEcCtD
Cefotetan—Haemorrhage—Vinblastine—kidney cancer	0.00456	0.00503	CcSEcCtD
Cefotetan—Haemorrhage—Everolimus—kidney cancer	0.00454	0.00501	CcSEcCtD
Cefotetan—Pancytopenia—Sunitinib—kidney cancer	0.0045	0.00497	CcSEcCtD
Cefotetan—Leukopenia—Pazopanib—kidney cancer	0.00448	0.00495	CcSEcCtD
Cefotetan—Neutropenia—Sunitinib—kidney cancer	0.00443	0.00489	CcSEcCtD
Cefotetan—Haemoglobin—Erlotinib—kidney cancer	0.00441	0.00486	CcSEcCtD
Cefotetan—Blood bilirubin increased—Capecitabine—kidney cancer	0.0044	0.00486	CcSEcCtD
Cefotetan—Haemorrhage—Erlotinib—kidney cancer	0.00438	0.00484	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00436	0.0048	CcSEcCtD
Cefotetan—Anaphylactic shock—Temsirolimus—kidney cancer	0.00434	0.00479	CcSEcCtD
Cefotetan—Thrombocytosis—Doxorubicin—kidney cancer	0.00432	0.00476	CcSEcCtD
Cefotetan—Phlebitis—Paclitaxel—kidney cancer	0.00428	0.00472	CcSEcCtD
Cefotetan—Pancytopenia—Dactinomycin—kidney cancer	0.00426	0.0047	CcSEcCtD
Cefotetan—Thrombocytopenia—Temsirolimus—kidney cancer	0.00425	0.00469	CcSEcCtD
Cefotetan—Neutropenia—Dactinomycin—kidney cancer	0.0042	0.00463	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.00419	0.00462	CcSEcCtD
Cefotetan—Erythema multiforme—Erlotinib—kidney cancer	0.00415	0.00457	CcSEcCtD
Cefotetan—Thrombocytopenia—Pazopanib—kidney cancer	0.004	0.00442	CcSEcCtD
Cefotetan—Colitis—Capecitabine—kidney cancer	0.004	0.00441	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00397	0.00438	CcSEcCtD
Cefotetan—Haemoglobin—Sorafenib—kidney cancer	0.00396	0.00437	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Gemcitabine—kidney cancer	0.00396	0.00437	CcSEcCtD
Cefotetan—Haemorrhage—Sorafenib—kidney cancer	0.00394	0.00435	CcSEcCtD
Cefotetan—Haemoglobin—Sunitinib—kidney cancer	0.00381	0.00421	CcSEcCtD
Cefotetan—Pancytopenia—Vincristine—kidney cancer	0.00381	0.0042	CcSEcCtD
Cefotetan—Haemorrhage—Sunitinib—kidney cancer	0.0038	0.00419	CcSEcCtD
Cefotetan—Neutropenia—Vincristine—kidney cancer	0.00375	0.00414	CcSEcCtD
Cefotetan—Agranulocytosis—Dactinomycin—kidney cancer	0.00373	0.00412	CcSEcCtD
Cefotetan—Erythema multiforme—Sorafenib—kidney cancer	0.00373	0.00411	CcSEcCtD
Cefotetan—Pancytopenia—Gemcitabine—kidney cancer	0.00361	0.00399	CcSEcCtD
Cefotetan—Erythema multiforme—Sunitinib—kidney cancer	0.00359	0.00396	CcSEcCtD
Cefotetan—Neutropenia—Gemcitabine—kidney cancer	0.00356	0.00392	CcSEcCtD
Cefotetan—Leukopenia—Vinblastine—kidney cancer	0.00355	0.00392	CcSEcCtD
Cefotetan—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00355	0.00391	CcSEcCtD
Cefotetan—Leukopenia—Everolimus—kidney cancer	0.00354	0.00391	CcSEcCtD
Cefotetan—Phlebitis—Capecitabine—kidney cancer	0.00351	0.00387	CcSEcCtD
Cefotetan—Hepatic function abnormal—Capecitabine—kidney cancer	0.00346	0.00382	CcSEcCtD
Cefotetan—Convulsion—Vinblastine—kidney cancer	0.00344	0.00379	CcSEcCtD
Cefotetan—Abdominal pain—Temsirolimus—kidney cancer	0.00343	0.00378	CcSEcCtD
Cefotetan—Body temperature increased—Temsirolimus—kidney cancer	0.00343	0.00378	CcSEcCtD
Cefotetan—Convulsion—Everolimus—kidney cancer	0.00343	0.00378	CcSEcCtD
Cefotetan—Erythema multiforme—Dactinomycin—kidney cancer	0.0034	0.00375	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00336	0.00371	CcSEcCtD
Cefotetan—Haemolytic anaemia—Capecitabine—kidney cancer	0.00335	0.0037	CcSEcCtD
Cefotetan—Gastrointestinal pain—Pazopanib—kidney cancer	0.00334	0.00369	CcSEcCtD
Cefotetan—Discomfort—Vinblastine—kidney cancer	0.00334	0.00368	CcSEcCtD
Cefotetan—Discomfort—Everolimus—kidney cancer	0.00333	0.00367	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00332	0.00366	CcSEcCtD
Cefotetan—Abdominal pain—Pazopanib—kidney cancer	0.00323	0.00356	CcSEcCtD
Cefotetan—Hypersensitivity—Temsirolimus—kidney cancer	0.0032	0.00353	CcSEcCtD
Cefotetan—Thrombocytopenia—Vinblastine—kidney cancer	0.00317	0.0035	CcSEcCtD
Cefotetan—Agranulocytosis—Gemcitabine—kidney cancer	0.00317	0.00349	CcSEcCtD
Cefotetan—Thrombocytopenia—Everolimus—kidney cancer	0.00316	0.00349	CcSEcCtD
Cefotetan—Leukopenia—Sorafenib—kidney cancer	0.00307	0.00339	CcSEcCtD
Cefotetan—Pruritus—Temsirolimus—kidney cancer	0.00307	0.00339	CcSEcCtD
Cefotetan—Haemoglobin—Gemcitabine—kidney cancer	0.00306	0.00338	CcSEcCtD
Cefotetan—Thrombocytopenia—Erlotinib—kidney cancer	0.00305	0.00336	CcSEcCtD
Cefotetan—Haemorrhage—Gemcitabine—kidney cancer	0.00305	0.00336	CcSEcCtD
Cefotetan—Pancytopenia—Paclitaxel—kidney cancer	0.00302	0.00334	CcSEcCtD
Cefotetan—Neutropenia—Paclitaxel—kidney cancer	0.00298	0.00329	CcSEcCtD
Cefotetan—Diarrhoea—Temsirolimus—kidney cancer	0.00297	0.00328	CcSEcCtD
Cefotetan—Leukopenia—Sunitinib—kidney cancer	0.00296	0.00326	CcSEcCtD
Cefotetan—Pruritus—Pazopanib—kidney cancer	0.00289	0.00319	CcSEcCtD
Cefotetan—Erythema multiforme—Gemcitabine—kidney cancer	0.00288	0.00318	CcSEcCtD
Cefotetan—Convulsion—Sunitinib—kidney cancer	0.00286	0.00316	CcSEcCtD
Cefotetan—Blood bilirubin increased—Doxorubicin—kidney cancer	0.00284	0.00313	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00282	0.00311	CcSEcCtD
Cefotetan—Anaphylactic shock—Sorafenib—kidney cancer	0.0028	0.00309	CcSEcCtD
Cefotetan—Leukopenia—Dactinomycin—kidney cancer	0.0028	0.00309	CcSEcCtD
Cefotetan—Diarrhoea—Pazopanib—kidney cancer	0.0028	0.00309	CcSEcCtD
Cefotetan—Vomiting—Temsirolimus—kidney cancer	0.00276	0.00304	CcSEcCtD
Cefotetan—Thrombocytopenia—Sorafenib—kidney cancer	0.00274	0.00303	CcSEcCtD
Cefotetan—Rash—Temsirolimus—kidney cancer	0.00274	0.00302	CcSEcCtD
Cefotetan—Dermatitis—Temsirolimus—kidney cancer	0.00273	0.00302	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00272	0.003	CcSEcCtD
Cefotetan—Vaginal inflammation—Doxorubicin—kidney cancer	0.00269	0.00296	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vinblastine—kidney cancer	0.00265	0.00292	CcSEcCtD
Cefotetan—Thrombocytopenia—Sunitinib—kidney cancer	0.00264	0.00291	CcSEcCtD
Cefotetan—Gastrointestinal pain—Everolimus—kidney cancer	0.00264	0.00291	CcSEcCtD
Cefotetan—Discomfort—Dactinomycin—kidney cancer	0.00263	0.0029	CcSEcCtD
Cefotetan—Vomiting—Pazopanib—kidney cancer	0.0026	0.00287	CcSEcCtD
Cefotetan—Colitis—Doxorubicin—kidney cancer	0.00258	0.00284	CcSEcCtD
Cefotetan—Rash—Pazopanib—kidney cancer	0.00258	0.00284	CcSEcCtD
Cefotetan—Nausea—Temsirolimus—kidney cancer	0.00258	0.00284	CcSEcCtD
Cefotetan—Dermatitis—Pazopanib—kidney cancer	0.00258	0.00284	CcSEcCtD
Cefotetan—Haemoglobin—Paclitaxel—kidney cancer	0.00256	0.00283	CcSEcCtD
Cefotetan—Abdominal pain—Vinblastine—kidney cancer	0.00256	0.00283	CcSEcCtD
Cefotetan—Abdominal pain—Everolimus—kidney cancer	0.00255	0.00281	CcSEcCtD
Cefotetan—Body temperature increased—Everolimus—kidney cancer	0.00255	0.00281	CcSEcCtD
Cefotetan—Haemorrhage—Paclitaxel—kidney cancer	0.00255	0.00281	CcSEcCtD
Cefotetan—Gastrointestinal pain—Erlotinib—kidney cancer	0.00255	0.00281	CcSEcCtD
Cefotetan—Vaginal infection—Doxorubicin—kidney cancer	0.00254	0.0028	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—kidney cancer	0.00252	0.00278	CcSEcCtD
Cefotetan—Leukopenia—Vincristine—kidney cancer	0.0025	0.00276	CcSEcCtD
Cefotetan—Thrombocytopenia—Dactinomycin—kidney cancer	0.0025	0.00276	CcSEcCtD
Cefotetan—Pancytopenia—Capecitabine—kidney cancer	0.00248	0.00274	CcSEcCtD
Cefotetan—Abdominal pain—Erlotinib—kidney cancer	0.00246	0.00272	CcSEcCtD
Cefotetan—Body temperature increased—Erlotinib—kidney cancer	0.00246	0.00272	CcSEcCtD
Cefotetan—Neutropenia—Capecitabine—kidney cancer	0.00244	0.0027	CcSEcCtD
Cefotetan—Nausea—Pazopanib—kidney cancer	0.00243	0.00268	CcSEcCtD
Cefotetan—Convulsion—Vincristine—kidney cancer	0.00242	0.00267	CcSEcCtD
Cefotetan—Erythema multiforme—Paclitaxel—kidney cancer	0.00241	0.00266	CcSEcCtD
Cefotetan—Hypersensitivity—Vinblastine—kidney cancer	0.00239	0.00263	CcSEcCtD
Cefotetan—Hypersensitivity—Everolimus—kidney cancer	0.00238	0.00262	CcSEcCtD
Cefotetan—Leukopenia—Gemcitabine—kidney cancer	0.00237	0.00262	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00231	0.00255	CcSEcCtD
Cefotetan—Gastrointestinal pain—Sorafenib—kidney cancer	0.00229	0.00253	CcSEcCtD
Cefotetan—Pruritus—Everolimus—kidney cancer	0.00228	0.00252	CcSEcCtD
Cefotetan—Anaphylactic shock—Vincristine—kidney cancer	0.00228	0.00252	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—kidney cancer	0.00226	0.0025	CcSEcCtD
Cefotetan—Thrombocytopenia—Vincristine—kidney cancer	0.00223	0.00246	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00223	0.00246	CcSEcCtD
Cefotetan—Discomfort—Gemcitabine—kidney cancer	0.00223	0.00246	CcSEcCtD
Cefotetan—Urticaria—Sorafenib—kidney cancer	0.00223	0.00246	CcSEcCtD
Cefotetan—Diarrhoea—Vinblastine—kidney cancer	0.00222	0.00245	CcSEcCtD
Cefotetan—Abdominal pain—Sorafenib—kidney cancer	0.00222	0.00244	CcSEcCtD
Cefotetan—Body temperature increased—Sorafenib—kidney cancer	0.00222	0.00244	CcSEcCtD
Cefotetan—Diarrhoea—Everolimus—kidney cancer	0.00221	0.00244	CcSEcCtD
Cefotetan—Gastrointestinal pain—Sunitinib—kidney cancer	0.0022	0.00243	CcSEcCtD
Cefotetan—Pruritus—Erlotinib—kidney cancer	0.0022	0.00243	CcSEcCtD
Cefotetan—Agranulocytosis—Capecitabine—kidney cancer	0.00217	0.0024	CcSEcCtD
Cefotetan—Anaphylactic shock—Gemcitabine—kidney cancer	0.00216	0.00239	CcSEcCtD
Cefotetan—Abdominal pain—Sunitinib—kidney cancer	0.00213	0.00235	CcSEcCtD
Cefotetan—Body temperature increased—Sunitinib—kidney cancer	0.00213	0.00235	CcSEcCtD
Cefotetan—Diarrhoea—Erlotinib—kidney cancer	0.00213	0.00235	CcSEcCtD
Cefotetan—Thrombocytopenia—Gemcitabine—kidney cancer	0.00212	0.00234	CcSEcCtD
Cefotetan—Haemoglobin—Capecitabine—kidney cancer	0.0021	0.00232	CcSEcCtD
Cefotetan—Haemorrhage—Capecitabine—kidney cancer	0.00209	0.00231	CcSEcCtD
Cefotetan—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00209	0.0023	CcSEcCtD
Cefotetan—Hypersensitivity—Sorafenib—kidney cancer	0.00206	0.00228	CcSEcCtD
Cefotetan—Vomiting—Vinblastine—kidney cancer	0.00206	0.00227	CcSEcCtD
Cefotetan—Vomiting—Everolimus—kidney cancer	0.00205	0.00226	CcSEcCtD
Cefotetan—Rash—Everolimus—kidney cancer	0.00204	0.00224	CcSEcCtD
Cefotetan—Dermatitis—Everolimus—kidney cancer	0.00203	0.00224	CcSEcCtD
Cefotetan—Body temperature increased—Dactinomycin—kidney cancer	0.00202	0.00223	CcSEcCtD
Cefotetan—Abdominal pain—Dactinomycin—kidney cancer	0.00202	0.00223	CcSEcCtD
Cefotetan—Leukopenia—Paclitaxel—kidney cancer	0.00199	0.00219	CcSEcCtD
Cefotetan—Hypersensitivity—Sunitinib—kidney cancer	0.00199	0.00219	CcSEcCtD
Cefotetan—Pruritus—Sorafenib—kidney cancer	0.00198	0.00219	CcSEcCtD
Cefotetan—Vomiting—Erlotinib—kidney cancer	0.00198	0.00218	CcSEcCtD
Cefotetan—Erythema multiforme—Capecitabine—kidney cancer	0.00198	0.00218	CcSEcCtD
Cefotetan—Rash—Erlotinib—kidney cancer	0.00196	0.00217	CcSEcCtD
Cefotetan—Dermatitis—Erlotinib—kidney cancer	0.00196	0.00216	CcSEcCtD
Cefotetan—Nausea—Vinblastine—kidney cancer	0.00192	0.00212	CcSEcCtD
Cefotetan—Convulsion—Paclitaxel—kidney cancer	0.00192	0.00212	CcSEcCtD
Cefotetan—Nausea—Everolimus—kidney cancer	0.00192	0.00211	CcSEcCtD
Cefotetan—Diarrhoea—Sorafenib—kidney cancer	0.00192	0.00211	CcSEcCtD
Cefotetan—Pruritus—Sunitinib—kidney cancer	0.00191	0.0021	CcSEcCtD
Cefotetan—Hypersensitivity—Dactinomycin—kidney cancer	0.00188	0.00207	CcSEcCtD
Cefotetan—Discomfort—Paclitaxel—kidney cancer	0.00187	0.00206	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vincristine—kidney cancer	0.00186	0.00206	CcSEcCtD
Cefotetan—Nausea—Erlotinib—kidney cancer	0.00185	0.00204	CcSEcCtD
Cefotetan—Diarrhoea—Sunitinib—kidney cancer	0.00184	0.00203	CcSEcCtD
Cefotetan—Anaphylactic shock—Paclitaxel—kidney cancer	0.00181	0.002	CcSEcCtD
Cefotetan—Abdominal pain—Vincristine—kidney cancer	0.0018	0.00199	CcSEcCtD
Cefotetan—Body temperature increased—Vincristine—kidney cancer	0.0018	0.00199	CcSEcCtD
Cefotetan—Vomiting—Sorafenib—kidney cancer	0.00178	0.00197	CcSEcCtD
Cefotetan—Thrombocytopenia—Paclitaxel—kidney cancer	0.00177	0.00196	CcSEcCtD
Cefotetan—Rash—Sorafenib—kidney cancer	0.00177	0.00195	CcSEcCtD
Cefotetan—Dermatitis—Sorafenib—kidney cancer	0.00177	0.00195	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00176	0.00194	CcSEcCtD
Cefotetan—Diarrhoea—Dactinomycin—kidney cancer	0.00175	0.00193	CcSEcCtD
Cefotetan—Vomiting—Sunitinib—kidney cancer	0.00171	0.00189	CcSEcCtD
Cefotetan—Body temperature increased—Gemcitabine—kidney cancer	0.00171	0.00189	CcSEcCtD
Cefotetan—Rash—Sunitinib—kidney cancer	0.0017	0.00188	CcSEcCtD
Cefotetan—Dermatitis—Sunitinib—kidney cancer	0.0017	0.00187	CcSEcCtD
Cefotetan—Hypersensitivity—Vincristine—kidney cancer	0.00168	0.00185	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—kidney cancer	0.00167	0.00184	CcSEcCtD
Cefotetan—Nausea—Sorafenib—kidney cancer	0.00166	0.00184	CcSEcCtD
Cefotetan—Leukopenia—Capecitabine—kidney cancer	0.00163	0.0018	CcSEcCtD
Cefotetan—Vomiting—Dactinomycin—kidney cancer	0.00162	0.00179	CcSEcCtD
Cefotetan—Rash—Dactinomycin—kidney cancer	0.00161	0.00178	CcSEcCtD
Cefotetan—Nausea—Sunitinib—kidney cancer	0.0016	0.00177	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—kidney cancer	0.0016	0.00176	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—kidney cancer	0.00158	0.00174	CcSEcCtD
Cefotetan—Diarrhoea—Vincristine—kidney cancer	0.00156	0.00172	CcSEcCtD
Cefotetan—Discomfort—Capecitabine—kidney cancer	0.00153	0.00169	CcSEcCtD
Cefotetan—Pruritus—Gemcitabine—kidney cancer	0.00153	0.00169	CcSEcCtD
Cefotetan—Nausea—Dactinomycin—kidney cancer	0.00152	0.00167	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00149	0.00164	CcSEcCtD
Cefotetan—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00148	0.00163	CcSEcCtD
Cefotetan—Diarrhoea—Gemcitabine—kidney cancer	0.00148	0.00163	CcSEcCtD
Cefotetan—Thrombocytopenia—Capecitabine—kidney cancer	0.00146	0.00161	CcSEcCtD
Cefotetan—Vomiting—Vincristine—kidney cancer	0.00145	0.0016	CcSEcCtD
Cefotetan—Urticaria—Paclitaxel—kidney cancer	0.00144	0.00159	CcSEcCtD
Cefotetan—Rash—Vincristine—kidney cancer	0.00144	0.00159	CcSEcCtD
Cefotetan—Dermatitis—Vincristine—kidney cancer	0.00144	0.00158	CcSEcCtD
Cefotetan—Body temperature increased—Paclitaxel—kidney cancer	0.00143	0.00158	CcSEcCtD
Cefotetan—Abdominal pain—Paclitaxel—kidney cancer	0.00143	0.00158	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—kidney cancer	0.0014	0.00155	CcSEcCtD
Cefotetan—Vomiting—Gemcitabine—kidney cancer	0.00138	0.00152	CcSEcCtD
Cefotetan—Rash—Gemcitabine—kidney cancer	0.00136	0.0015	CcSEcCtD
Cefotetan—Dermatitis—Gemcitabine—kidney cancer	0.00136	0.0015	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—kidney cancer	0.00136	0.0015	CcSEcCtD
Cefotetan—Nausea—Vincristine—kidney cancer	0.00135	0.00149	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—kidney cancer	0.00135	0.00149	CcSEcCtD
Cefotetan—Hypersensitivity—Paclitaxel—kidney cancer	0.00133	0.00147	CcSEcCtD
Cefotetan—Nausea—Gemcitabine—kidney cancer	0.00129	0.00142	CcSEcCtD
Cefotetan—Pruritus—Paclitaxel—kidney cancer	0.00128	0.00141	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—kidney cancer	0.00128	0.00141	CcSEcCtD
Cefotetan—Diarrhoea—Paclitaxel—kidney cancer	0.00124	0.00137	CcSEcCtD
Cefotetan—Gastrointestinal pain—Capecitabine—kidney cancer	0.00122	0.00134	CcSEcCtD
Cefotetan—Urticaria—Capecitabine—kidney cancer	0.00118	0.0013	CcSEcCtD
Cefotetan—Abdominal pain—Capecitabine—kidney cancer	0.00118	0.0013	CcSEcCtD
Cefotetan—Body temperature increased—Capecitabine—kidney cancer	0.00118	0.0013	CcSEcCtD
Cefotetan—Vomiting—Paclitaxel—kidney cancer	0.00115	0.00127	CcSEcCtD
Cefotetan—Rash—Paclitaxel—kidney cancer	0.00114	0.00126	CcSEcCtD
Cefotetan—Dermatitis—Paclitaxel—kidney cancer	0.00114	0.00126	CcSEcCtD
Cefotetan—Hypersensitivity—Capecitabine—kidney cancer	0.0011	0.00121	CcSEcCtD
Cefotetan—Nausea—Paclitaxel—kidney cancer	0.00108	0.00119	CcSEcCtD
Cefotetan—Pruritus—Capecitabine—kidney cancer	0.00105	0.00116	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—kidney cancer	0.00105	0.00116	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—kidney cancer	0.00102	0.00112	CcSEcCtD
Cefotetan—Diarrhoea—Capecitabine—kidney cancer	0.00102	0.00112	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—kidney cancer	0.000988	0.00109	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—kidney cancer	0.000958	0.00106	CcSEcCtD
Cefotetan—Vomiting—Capecitabine—kidney cancer	0.000945	0.00104	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—kidney cancer	0.000938	0.00103	CcSEcCtD
Cefotetan—Rash—Capecitabine—kidney cancer	0.000937	0.00103	CcSEcCtD
Cefotetan—Dermatitis—Capecitabine—kidney cancer	0.000936	0.00103	CcSEcCtD
Cefotetan—Nausea—Capecitabine—kidney cancer	0.000883	0.000974	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000784	0.000864	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—kidney cancer	0.000761	0.00084	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—kidney cancer	0.000757	0.000835	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—kidney cancer	0.000757	0.000835	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—kidney cancer	0.000706	0.000779	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—kidney cancer	0.000678	0.000748	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—kidney cancer	0.000656	0.000723	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—kidney cancer	0.000609	0.000672	CcSEcCtD
Cefotetan—Rash—Doxorubicin—kidney cancer	0.000604	0.000666	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—kidney cancer	0.000604	0.000666	CcSEcCtD
Cefotetan—Nausea—Doxorubicin—kidney cancer	0.000569	0.000628	CcSEcCtD
